New mRNA vaccine platform provides stronger protection against SARS-CoV-2 delta variant

By | December 14, 2021
A group of researchers from various institutions developed a nucleoside-modified mRNA vaccine that encodes the SARS-CoV-2 N protein (mRNA-N) and is formulated in lipid nanoparticles for this investigation (LNP).